In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating mRNA

MLA

Breda, Laura, et al. “In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating MRNA.” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 305–06. EBSCOhost, https://doi.org/10.1182/blood-2022-165089.

APA

Breda, L., Papp, T. E., Triebwasser, M., Yadegari, A., Fedorky, M. T., Tanaka, N., Ni, H., Weissman, D., Rivella, S., & Parhiz, H. (2022). In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating mRNA. Blood, 140(1, Number 1 Supplement 1), 305–306. https://doi.org/10.1182/blood-2022-165089

Chicago

Breda, Laura, Tyler E Papp, Michael Triebwasser, Amir Yadegari, Megan T Fedorky, Naoto Tanaka, Houping Ni, Drew Weissman, Stefano Rivella, and Hamideh Parhiz. 2022. “In Vivo Modification of Hematopoietic Stem Cells By Targeted Lipid Nanoparticles Encapsulating MRNA.” Blood 140 (1, Number 1 Supplement 1): 305–6. doi:10.1182/blood-2022-165089.